High materiality7/10
Abbvie (ABBV) PT Raised to $290 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Target $290; price $250.88; Canaccord Genuity.
- Target $290; price $250.88; upside ~16%.
Key facts
- 01
Target: $290
- 02
Posted price: $250.88
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Gary Nachman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.